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Background: Herpes simplex virus (HSV) encephalitis is the most common sporadic cause of encephalitis with
significant morbidity and mortality that is drastically reduced by early antiviral treatment.
Case presentation: We report a 37 year old woman, 33 weeks pregnant, who presented with seizures due to
proven HSV-1 encephalitis, and who had had a previous episode of probable viral encephalitis aged 14 years. She
was successfully treated with aciclovir on both occasions and, in the latter, went on to deliver a healthy infant. This
case is compared with 17 cases of HSV encephalitis in pregnancy in the literature identifying a predominance in the
late 2nd and 3rd trimesters, perhaps in part due to immunological changes in pregnancy. The clinical presentation is
also compared with non-pregnant patients with HSV encephalitis in the largest prospective UK and European studies.
We also present practical advice on management from recent national guidelines.
Conclusion: When pregnant women present with new seizures, headache, impaired consciousness or altered behaviour
urgent investigation is required to identify common diagnoses, such as eclampsia, venous sinus thrombosis and
metabolic disturbances. Nevertheless, viral encephalitis is a very treatable cause of this presentation with potentially
serious complications if missed, and may be more common in latter stages of pregnancy. Encephalitis should not be
discounted if the patient is afebrile, has a normal Glasgow coma score, or the cerebrospinal fluid white cell count is only
slightly elevated, as these features are well recognised in viral encephalitis.
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Herpes simplex virus is the most common sporadic
cause of encephalitis, with the majority of cases due to
HSV type-1. Early investigation and treatment is critical,
as mortality is reduced from >70% to <20-30% [1,2].
HSV encephalitis has been described in pregnancy but
little is known about how the clinical presentation and
outcome compare between this group and those with
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To assess if the clinical presentation and outcome in
pregnant patients differs from non-pregnant patients, we
first describe a case of HSV encephalitis in pregnancy. In
addition, a Medline search for previous case reports
of HSV encephalitis in pregnant women in English
(between 1972 and 2013) was performed, using the
search terms herpes simplex encephalitis and pregnancy.
Cases with HSV type 1 and type 2 were identified,
but were only included if they met established clinical
case definitions for encephalitis, namely encephalopathy
(altered consciousness that persisted for longer than
24 hours, including lethargy, irritability, or a change
in personality and behaviour) and two or more of the
following: fever or history of fever (≥38°C) during the
presenting illness; seizures and/or focal neurologicalhis is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly credited. The Creative Commons Public Domain
g/publicdomain/zero/1.0/) applies to the data made available in this article,







Type Admission Investigations Treatment Outcome
Febrile GCS Symptoms CSF CT/MRI EEG
2015 Dodd
KC (This case)





WCC 10 MRI - Initially
normal, then
increased signal







IV aciclovir 10 mg/kg
TDS stopped after
















WCC 345 MRI - Hyperintensity
with oedema in the
right temporal area
and cerebral peduncle
Not done IV aciclovir 10 mg/kg
TDS stopped after










Mesker AJ et al.
2013 Dodd KC,
et al. [11]






CT +MRI - Abnormalities
in right temporal lobe




at 37 weeks –
healthy child.
Dexamethasone
10 mg QDS 4 days
Patient improved










WCC 125 MRI - Right temporopolar
and medial hyperintensity,
with cytotoxic oedema
Not done IV aciclovir 12.5 mg/kg




at 33 weeks due
to deterioration.










WCC 70 MRI - Increased signal






IV aciclovir 750 mg
TDS for 21 days
Normal vaginal
delivery at term.
HSV-1 PCR Dexamethasone –
reducing regimen
28 days

























































Table 1 Previous HSV encephalitis in pregnancy case reports (Continued)
1999 Dupuis O,
et al.[16]














HSV-1 PCR MRI - Abnormal signal in



























by day 23. Seizure
recurrence at




1992 Luby JP.[17] 15 35 1 Y 15 Fever, nausea, sore
throat, and headache.
WCC 398 CT - A low density
area in the right
temporal lobe
Not done Aciclovir 10 mg/kg













28 21 NK Y NK Fever and acute
confusional state.
Mild right hemiparesis.


























and type 2 (>1:400)
CT - Low density
















well on day 11.
Forceps delivery






25 mg IV QDS
1989 Besser R
et al.[20]











































Table 1 Previous HSV encephalitis in pregnancy case reports (Continued)
healthy child 16
weeks later.







































41 32 2 Y NK Fever, confusion, seizures,
and then stupor.






Aciclovir IV 10 mg/kg
TDS on day 5 for
3 doses and then






















Campos G, et al.[7]
22 16 NK N NK Spontaneous abortion,






















Campos G, et al.[7]
17 24 NK N NK Bizarre behaviour,
a week later coma
and then seizures.





































Table 1 Previous HSV encephalitis in pregnancy case reports (Continued)
1972 Anderson JM,
et al.[23]











































Dodd et al. BMC Research Notes  (2015) 8:118 Page 6 of 10findings (with evidence of brain parenchyma involvement);
CSF pleocytosis (>4cells/μL); electroencephalographic
findings indicative of encephalitis; and abnormal results
of neuroimaging (computed tomography or magnetic
resonance imaging) suggestive of encephalitis [3,4].
Data from these cases were compared with those from the
two largest multicentre prospective studies of HSV
encephalitis in the UK and Europe; the authors of the UK
paper were approached to provide additional raw data
when required [4,5]. Univariate analysis was performed
using the chi-squared Fisher’s exact test for categorical
variables and the Mann–Whitney U test for continuous
data using SPSS 2012©. A Glasgow coma score (GCS)
of <8 was defined as coma and statistical significance as a
p value of <0.05.
Case presentation
A 37 year old right-handed woman, who was 33 weeks
pregnant (gravida 5, para 3), presented following a first
seizure. She had a preceding 10-day history of diarrhoea,
vomiting, photophobia and severe headache, which woke
her up from sleep and was exacerbated by coughing.
There was no recent travel or head injury. A witness
reported that she had visual hallucinations, followed
by an episode of inappropriate laughter and within
minutes a secondary generalised seizure: her right
arm moved over her chest and her head deviated to
the right, followed by her whole body becoming stiff,
with clonic movements of all limbs. She became cyanosed,
bit her tongue, had urinary incontinence and was unrou-
sable. This lasted for approximately five minutes, followed
by post-ictal drowsiness for two hours.
At presentation to the local teaching hospital she
was apyrexial, had a GCS of 15/15, and normal
cardio-respiratory and neurological examinations. She
was not hypertensive and urinalysis did not demonstrate
proteinuria. Her full blood count, renal, liver and bone
profiles were normal, the erythrocyte sedimentation rate
was 39 (reference range 5–15) mm/hr and C-reactive pro-
tein was 6 (<10) mg/L. Magnetic resonance imaging
(MRI) and venography of the brain on day one were nor-
mal. Oral carbamazepine was commenced and, following
a second tonic-clonic seizure 16 hours after admission,
oral clobazam was added.
A lumbar puncture (LP) demonstrated an opening
pressure of 14 (reference range 7–18) cm, CSF white
cells count (WCC) 10 (<5) ×106/L, with predominance
of immature neutrophils (percentage not known), red cell
count (RCC) 2 (0–10) ×106/L, protein 0.23 (0.15-0.4) g/L,
and CSF glucose 3.6 (2.8-4.2) mmol/L, 67% of blood
glucose. No organisms were seen, and oligoclonal
bands were negative. On receipt of these results,
intravenous aciclovir was commenced; approximately
25 hours after admission.On day two she developed fluctuating confusion, abnor-
mal behaviour and a temperature of 37.8°C. Her GCS
deteriorated to 11/15 (eyes opening to speech, incom-
prehensible sounds and obeying commands), and she
had a positive Babinski’s sign on the right. She was
given intravenous phenytoin, for clinically suspected
non-convulsive status epilepticus.
The patient had previously been admitted, when aged 14,
with acute headache, confusion, vomiting, photophobia
and diplopia. LP demonstrated a CSF protein of 0.8
(0.15-0.4) g/L, glucose 3.6 (2.8-4.2) mmol/L, WCC 1
(0–5) ×106/mm3, RCC 38 (0–10) ×106/L, and no organ-
isms were seen. Viral polymerase chain reaction (PCR)
analysis and antibody testing were not available. A com-
puted tomography (CT) scan of the brain demonstrated
small ventricles with early cerebral oedema. A full course
of intravenous aciclovir was given for presumed HSV
encephalitis. She made a full and uneventful recovery.
In the current admission, CSF PCR returned positive
for HSV type-1 and negative for HSV type-2, varicella
zoster virus and enterovirus. Electroencephalography
(EEG) showed left fronto-temporal epileptiform discharges,
and repeat MRI on day three showed classic changes
of herpes simplex encephalitis with high signal on dif-
fusion weighted imaging of the left temporal pole and
left insular cortex.
The aciclovir was stopped after 16 days, following
repeat CSF HSV-1 PCR testing negative. Foetal growth
scans and foetal heart rate monitoring were normal
throughout. An elective caesarean section at 39 weeks was
undertaken with no complications, and a healthy boy, of
3.725 kg, was delivered. The neonate was not given
aciclovir. A repeat EEG prior to discharge showed
marked improvement albeit with some residual slowing.
Phenytoin and clobazam were gradually tapered off
and carbamazepine continued. At six month follow-
up the patient is well with no seizure recurrence and
the child was healthy.
Results
21 cases were identified, four were excluded; two as
they contained cases of metabolic encephalopathy and
disseminated HSV-2 infection without encephalitis,
and two had no definite proof of HSV infection [6-9].
Therefore, 17 cases were included in the analysis and
these are summarised in Table 1 [7,10-23]. The majority
of cases occurred in the later stages of pregnancy, with 11
(61) in the 3rd trimester, 6 (33%) in the 2nd trimester and
only 1 (6%) in the 1st trimester.
In this case, the patient was afebrile and the CSF white
cell count was only slightly raised. In comparison to the
largest prospective UK cohort of 38 patients and the
European cohort of 98 patients, the proportion of
patients during pregnancy reported in the literature
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The mean WCC was also similar between the groups. In
this case, although there had been a preceding seizure, at
the time of initial clinical clerking assessment the GCS
was normal. Of the cases in the literature at presentation,
none of the eight pregnant patients in whom the GCS was
available had GCS <8, whereas this has previously been
seen in 24% of the general mixed sex population
with HSV-1 encephalitis and 9% of adults with HSV
encephalitis overall [4,5]. This may reflect an earlier
presentation in pregnant patients, as the median
(range) days of symptoms prior to admission was
shorter for pregnant patients, although this was not
statistically significant (3 [0–10] vs 6.5 [0–30], p = 0.35).
There are limitations in the interpretation of this data
as the case reports are from a wide time period and
there is variability in the data that is presented within
them. What would have been ideal, but was not possible
due to the limitations of the published data, would have
been to compare the time from onset of symptoms,
to onset of coma between pregnant patients with HSV1
encephalitis and an age and sex-matched cohort with
HSV1 encephalitis.
The outcome of pregnant patients treated for HSV
encephalitis appears not to be statistically different to
that in the general population. In those patients treated
with aciclovir (n = 15), only 1 women (7%), and 1 foetus,
died with on-going disability for 4 (27%) of the surviving
women. Nevertheless, of those not given aciclovir (n = 6),
4 (67%) women and 3 (50%) foetuses died. In other
studies, mortality in HSV encephalitis treated withTable 2 Comparison between clinical features, investigation f





Fever 89% (16/18) 76% (29/38)
Headache 67% (12/18) 42% (16/38)
Seizures 45% (8/18) 63% (24/38)
Mean GCS on admission
(where documented)
14.6 NK
Coma on admission (GCS < 8,
where GCS documented)
0% (0/8) 24% (9/38)
Abnormal CT 40% (4/10) 56% (18/32)
(if performed)
Abnormal MRI 80% (8/10) 89% (25/28)
(if performed)
Abnormal EEG 92% (11/12) 81% (22/27)
(if performed)
WCC mean (range) 177 (0–623) 46 (10–1278
Death 3/18 (17%) 11% (4/38)
Footnote: Population 4: Granerod et al [4]; Population 5: Raschilas et al [5].aciclovir has been reported as 11% – 15%, without a
significant difference in outcome between sexes, although
this may reflect publication bias [4,5].
Discussion
Herpes simplex virus is the most common cause of
sporadic viral encephalitis with 90% of cases being
due to type-1 [1,4]. It usually presents as a concurrent or
antecedent febrile or coryzal illness with headache,
impaired cognition, reduced consciousness, changes in
personality and behaviour and seizures.
This patient had proven HSV-1 encephalitis when
pregnant aged 37, with an episode of encephalitis aged
14 which was of uncertain aetiology due to investigatory
limitations at the time of intitial presentation in childhood,
although HSV would be the most common cause and the
patient was treated for presumed HSV encephalitis.
Therefore, this may possibly represent a late relapse of
HSV-1 encephalitis during pregnancy, which has not
previously been reported, although more thorough
investigation at the time of the childhood illness would be
required to establish this. Relapse of HSV-1 encephalitis
is rare, but recognised, and can be either early, due
to suboptimal treatment or post-infectious immune
process, or late, with latencies previously reported of
up to 8.5 years [2,24].
During pregnancy, women may be at an increased risk
of certain infections, and also increased risk of severe
manifestations of infection [25-27]. There are many com-
plex immunological adaptations during in pregnancy, to
prevent rejection of the ‘foetal allograft’, which containsindings and outcome of HSV encephalitis in the general
pulation with
phalitis [4]
p value General population with
HSV encephalitis [5]
p value
0.75 92% (90/98) 0.22
0.1 NK NK
0.17 32% (31/98) 0.32
NK 13.7 NK
0.32 9% (9/98) 0.36
1.0 79% (72/91) 0.17
0.59 NK NK
0.64 NK NK
) 0.51 237 (1–3900) NK
0.67 13/85 (15%) 1.0
Figure 1 Algorithm for the management of patients with suspected viral encephalitis. (Reprinted from Journal of Infection, 64(4): 347–73,
Solomon T, Michael BD, Smith PE, et al. Management of suspected viral encephalitis in adults - Association of British Neurologists and British Infection
Association National Guidelines, Copyright 2012, with permission from Elsevier) [1].
Dodd et al. BMC Research Notes  (2015) 8:118 Page 8 of 10
Dodd et al. BMC Research Notes  (2015) 8:118 Page 9 of 10paternal antigens [25,26]. Oestrogens and progesterones
rise during pregnancy, are highest in the late 2nd and 3rd
trimesters, and are thought to modulate an immunological
shift, in both the cell-mediated and humoural systems
[25,26]. Interestingly the vast majority of cases of
HSV encephalitis identified in pregnancy occurred in
the 3rd trimester and, to a lesser extent in the 2nd
trimester, with only 2 occurring in the 1st trimester.
This may, however, relate to lower recognition of
pregnancy during the first trimester.
In pregnant women presenting with seizures, headache,
or altered behaviour, in addition to viral encephalitis the
differential diagnosis includes and number of other
structural and metabolic causes which must be excluded.
Hyperemesis gravidarum in early pregnancy results in
excessive vomiting producing electrolyte imbalance,
which, if severe, may provoke seizures [28]. Eclampsia
refers to seizures or coma as severe complications of
pre-eclapmsia; this is identified by hypertension and
proteinuria. Pregnancy increases blood viscosity and the
risk of thrombosis; therefore if seizures were preceded by
headache, especially if with features of raised intracranial
pressure, then an MR venogram should be performed.
Further differential diagnosis includes acute hepatitis,
malaria, ischaemic stroke, or acute intermittent porphyria
[29]. The UK guideline for the management of suspected
viral encephalitis recommend intravenous aciclovir as
soon as possible if the CSF or MRI findings suggest viral
encephalitis, or within 6 hours if these results are not
available (Figures 1 and 2) [1,27]. There are no specific
guidelines for management of viral encephalitis inFigure 2 Classical asymmetrical temporal lobe T2 hyperintensity
in a patient with Herpes Simplex Virus type-1 encephalitis.pregnancy, but there is accumulating evidence that
aciclovir is safe in pregnancy and is not associated
with an increase in birth defects [30]. As mortality in
HSV encephalitis is reduced from >70% to <20-30%
with aciclovir, and delay in starting treatment is asso-
ciated with a worse outcome, treatment should be
started promptly in all patients with suspected HSV
encephalitis [1,27,31]. In pregnant patients with sei-
zures the lowest effective dose of anti-epileptic drugs
is preferable, avoiding polytherapy and particularly
potentially teratogenic drugs [32]. Nevertheless, the
aim should be seizure freedom as there is a risk to
the foetus during tonic-clonic seizures [32]. There is
currently no evidence to support the use of anti-epileptic
drugs as primary prophylaxis in viral encephalitis, and
no evidence to direct secondary prophylaxis [33,34].
We identified that the cases of HSV encephalitis re-
ported in pregnancy often did not have a significantly
impaired GCS and that this may reflect an earlier pres-
entation of some patients in this group. However, there
are limitations in the interpretation of these data as
the case reports are from a wide time period and
there is variability in the data that is presented within
them. What would have been ideal, but was not possible
due to the limitations of the published data, would have
been to compare the time from onset of symptoms,
to onset of coma between pregnant patients with HSV1
encephalitis and an age and sex-matched cohort with
HSV1 encephalitis.
Conclusion
Urgent investigation for common diagnoses, such as
eclampsia, venous sinus thrombosis and metabolic
disturbance is required when pregnant women present
with headaches, new seizures, and changes in cogni-
tion or behaviour. HSV encephalitis is an additional
treatable cause of this presentation, with potentially
devastating consequences if missed, and may be more
common in the late 2nd and 3rd trimesters. Importantly,
HSV encephalitis should not be discounted in pregnant
patients presenting with a normal or near-normal GCS,
which can be seen in all patients with HSE, but may be
more common during pregnancy; possibly due to the
altered immune response, or earlier presentation. In
future, where possible, pregnant women should not be
excluded from studies of immunological responses during
viral encephalitis.
Consent
We have obtained the patient’s full consent for publica-
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Dodd et al. BMC Research Notes  (2015) 8:118 Page 10 of 10Abbreviations
HSV: Herpes Simplex Virus; GCS: Glasgow Coma Score; CSF: Cerebrospinal
Fluid; MRI: Magnetic Resonance Imaging; LP: Lumbar Puncture; WCC: White
cell count; RCC: Red cell count; PCR: Polymerase chain reaction;
CT: Computed tomography; EEG: Electroencephalogram.
Competing interests
The authors declare that they have no competing interests.
Authors’ contributions
KD participated in the design of the manuscript, performed the literature
search and drafted the manuscript. BDM also participated in the design of
the manuscript, drafted the manuscript, reviewed the literature, and
performed statistical analysis. BZ obtained the patients consent. BW, AK, RB
and TS all participated in the design and composition of the manuscript.
All authors made substantial contributions to conception and design,
acquisition of data, or analysis and interpretation of data; drafting the article
or revising it critically for important intellectual content; and final approval of
the version to be published.
Acknowledgements
BDM is an NIHR Academic Clinical Lecturer and received support as part of
an NIHR Doctoral Research Fellowship. TS received support from the MRC
and NIHR PHRU. The authors have not conflicts of interest to declare. The
research materials supporting this publication can be accessed by contacting
benedict.michael@liv.ac.uk.
Author details
1Royal Preston Hospital, Sharoe Green Lane North, Preston PR2 9HT, UK. 2The
Walton Centre Neurology NHS Foundation Trust, Lower Lane, Fazakerly,
Liverpool L9 7JL, UK. 3Institute of Infection and Global Health, University of
Liverpool, The Ronald Ross Building, West Derby Street, Liverpool L69 7BE,
UK. 4Liverpool Women’s Hospital, Crown Street, Liverpool L8 7SS, UK.
5Vaccine Evaluation Unit, Public Health England, Oxford Road, Manchester
M13 9WZ, UK.
Received: 6 January 2014 Accepted: 18 March 2015
References
1. Solomon T, Michael BD, Smith PE, Sanderson F, Davies NW, Hart IJ, et al.
Management of suspected viral encephalitis in adults – association of British
Neurologists and British Infection Association National Guidelines. J Infect.
2012;64:347–73.
2. Whitley RJ, Gnann JW. Viral encephalitis: familiar infections and emerging
pathogens. Lancet. 2002;359:507–13.
3. Michael BD, Sidhu M, Stoeter D, Roberts M, Beeching NJ, Bonington A, et al.
The epidemiology and management of adult suspected central nervous
system infections - a retrospective cohort study in the NHS Northwest
Region. Q J Med. 2010;103(10):749–5.
4. Granerod J, Ambrose HE, Davies NW, Clewley JP, Walsh AL, Morgan D, et al.
Causes of encephalitis and differences in their clinical presentations in
England: a multicentre, population-based prospective study. Lancet Infect
Dis. 2010;10:835–44.
5. Raschilas F, Wolff M, Delatour F, Chaffaut C, De Broucker T, Chevret S, et al.
Outcome of and prognostic factors for herpes simplex encephalitis in adult
patients: results of a multicentre study. Clin Infect Dis. 2013;35(3):254–60.
6. King RL. Herpes simplex encephalitis in pregnancy. Am J Obstet Gynecol.
1979;135:1114–5.
7. Roman-Campos G, Navarro De Roman LI, Toro G, Vergara I. Herpes
encephalitis in pregnancy. Am J Obstet Gynaecol. 1979;135:158–9.
8. Young EJ, Killam AP, Green FJ. Disseminated herpes virus infection. J Amer
Med Assoc. 1976;235:2731–3.
9. Klein NA, Mabie WC, Shaver DC, Latham PS, Adamec TA, Pinstein ML, et al.
Herpes simplex virus hepatitis in pregnancy: two patients successfully
treatment with aciclovir. Gastroenterology. 1991;100(1):239–44.
10. Pascal J, Perbet S, Bourdel N, Da Ines D, Tran X, Chartier C, et al.
Management of HSV-1 encephalitis due to reactivation of HSV-1 during later
pregnancy. Int J Obstet Anesth. 2012;21:364–7. doi: 10.1016/j.
ijoa.2012.05.004.11. Mesker AJ, Bon GG, de Gans J, de Krujik JR. Case report: a pregnant woman
with herpes simplex encephalitis successfully treated with dexamethasone.
Eur J Obstet Gynecol Reprod Biol. 2011;154:231–2.
12. Sellner J, Buonomano R, Nedeltchev K, Findling O, Schroth G, Surbek DV, et al.
A case of maternal herpes simplex virus encephalitis during later pregnancy.
Nat Clin Pract Neurol. 2009;5:51–6.
13. Piskin N, Akduman D, Aydemir H, Celebi G, Oztoprak N. Herpes simplex virus
encephalitis in pregnancy. J Matern Fetal Neonatal Med. 2008;21:421–3.
14. Gunduz A, Beskardes AF, Kutlu A, Ozkara C, Karaagac N, Yeni SN. Herpes
encephalitis as a cause of nonconvulsive status epilepticus. Epileptic Disord.
2006;8:57–60.
15. Godet C, Beby-Defaux A, Agius G, Pourrat O, Robert R. Maternal herpes
simplex virus type 2 encephalitis following cesarean section. J Infect.
2003;47:174–5.
16. Dupuis O, Audibert F, Fernandez H, Frydman R. Herpes simplex virus
encephalitis in pregnancy. Obstet Gynecol. 1999;94:810–2.
17. Luby JP. Southwestern internal medicine conference: infections of the
central nervous systems. Am J Med Sci. 1992;304:379–91.
18. Anteby E, Reches A, Lavy Y, Yagel S. Fetal serology in maternal HSV
encephalitis. Prenat Diagn. 1992;12:855–6.
19. Frieden FJ, Ordorica SA, Goodgold AL, Hoskins IA, Silverman F, Young BK.
Successful pregnancy with isolated herpes simplex virus encephalitis:
case report and review of the literature. Obstet Gynecol. 1990;75:511–3.
20. Besser R, Vogt T, Thömke F. Successful treatment of HSV encephalitis during
pregnancy. Neurology. 1989;39:748.
21. Hankey GJ, Bucens MR, Chambers JS. Herpes simplex encephalitis in third
trimester of pregnancy: successful outcome for mother and child.
Neurology. 1987;37:1534–7.
22. Berger SA, Weinberg M, Treves T, Sorkin P, Geller E, Yedwab G, et al. Herpes
encephalitis during pregnancy: failure of acyclovir and adenine arabinoside
to prevent neonatal herpes. Isr J Med Sci. 1986;22:41–4.
23. Anderson JM, Nicholls MW. Herpes encephalitis in pregnancy. Br Med J.
1972;1:632.
24. Spiegel R, Miron D, Yodko H, Lumelsky D, Habib A, Horovitz Y. Late relapse
of herpes simplex virus encephalitis in a child due to reactivation of latent
virus: clinicopathological report and review. J Child Neurol. 2008;23:344–8.
25. Chen SJ, Liu YL, Sytwu HK. Immunologic regulation in pregnancy: from
mechanism to therapeutic strategy for immunomodulation. Clin Dev
Immunol. 2012;2012:258391.
26. Robinson DP, Klein SL. Pregnancy and pregnancy-associated hormones alter
immune responses and disease pathogenesis. Horm Behav. 2012;62:263–71.
27. Kneen R, Michael BD, Menson E, Mehta B, Easton A, Hemingway C, et al.
Management of suspected viral encephalitis in children – association of
British Neurologists and British infection association national guidelines.
J Infect. 2012;64:449–77.
28. Rahuldeo J, Sushil K, Anupam A, Pragati T. Ventricular tachycardia and
seizure in hyperemesis gravidarum. J Obstet Gynecol India. 2010;60(4):339–40.
29. Beach RL, Kaplan PW. Seizures in pregnancy: diagnosis and management.
Int Rev Neurobiol. 2008;83:259–71. doi: 10.1016/S0074-7742(08)00015-9.
30. Kang SH, Chua-Gocheco A, Bozzo P, Einarson A. Safety of antiviral medication
for hte treatment of herpes during pregnancy. Can Fam Physician.
2011;57:427–8.
31. Tunkel AR, Glaser CA, Bloch KC, Sejvar JJ, Marra CM, Roos KL, et al. The
management of encephalitis: clinical practice guidelines by the Infectious
Diseases Society of America. Clin Infect Dis. 2008;47:303–27.
32. National Institute for Health and Clinical Excellence. The epilepsies: the
diagnosis and management of the epilepsies in adults and children in
primary and secondary care. Clinical guidelines, CG137. London: National
Institute for Health and Clinical Excellence; 2012.
33. Michael BD, Solomon T. Seizures and encephalitis: clinical features,
management, and potential pathophysiologic mechanisms. Epilepsia.
2012;53:63–71.
34. Pandey S, Rathore C, Michael BD. Antiepileptic drugs for the primary and
secondary prevention of seizures in viral encephalitis. Cochrane Database
Syst Rev. 2013:CD010247. doi:10.1002/14651858.
